imipramine and thromboxane b2

imipramine has been researched along with thromboxane b2 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Evans, FJ; Kakkar, VV; Westwick, J; Williamson, EM1
Bolen, J; DiFazio, L; Ginalis, E; Greco, R; Haimovich, B; Ji, P; Purohit, U; Regan, C; Rowley, RB1

Other Studies

2 other study(ies) available for imipramine and thromboxane b2

ArticleYear
Studies on the mechanism of action of 12-deoxyphorbolphenylacetate, a potent platelet aggregating tigliane ester.
    Biochemical pharmacology, 1981, Oct-01, Volume: 30, Issue:19

    Topics: Desipramine; Drug Stability; Humans; Imipramine; In Vitro Techniques; Male; Phorbol Esters; Phorbols; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Serotonin; Thromboxane B2

1981
The FcgammaRII receptor triggers pp125FAK phosphorylation in platelets.
    The Journal of biological chemistry, 1996, Jul-05, Volume: 271, Issue:27

    Topics: Antibodies, Monoclonal; Blood Platelets; Cell Adhesion Molecules; Chelating Agents; Cytoplasmic Granules; Egtazic Acid; Enzyme Inhibitors; Enzyme Precursors; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Imipramine; Immunoglobulin G; In Vitro Techniques; Indoles; Intracellular Signaling Peptides and Proteins; Maleimides; Phosphorylation; Phosphotyrosine; Platelet Adhesiveness; Platelet Aggregation; Protein-Tyrosine Kinases; Receptors, IgG; Serotonin; Syk Kinase; Thromboxane B2

1996